JP2019509748A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019509748A5 JP2019509748A5 JP2018550831A JP2018550831A JP2019509748A5 JP 2019509748 A5 JP2019509748 A5 JP 2019509748A5 JP 2018550831 A JP2018550831 A JP 2018550831A JP 2018550831 A JP2018550831 A JP 2018550831A JP 2019509748 A5 JP2019509748 A5 JP 2019509748A5
- Authority
- JP
- Japan
- Prior art keywords
- factor
- fine
- nucleic acid
- heterologous nucleic
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022070121A JP2022101642A (ja) | 2016-03-30 | 2022-04-21 | 組換えタンパク質及び／又はウイルスベクター製造のための細胞株 |
| JP2025019374A JP2025087704A (ja) | 2016-03-30 | 2025-02-07 | 組換えタンパク質及び／又はウイルスベクター製造のための細胞株 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662315480P | 2016-03-30 | 2016-03-30 | |
| US62/315,480 | 2016-03-30 | ||
| PCT/US2017/024951 WO2017173043A1 (en) | 2016-03-30 | 2017-03-30 | Cell line for recombinant protein and/or viral vector production |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022070121A Division JP2022101642A (ja) | 2016-03-30 | 2022-04-21 | 組換えタンパク質及び／又はウイルスベクター製造のための細胞株 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019509748A JP2019509748A (ja) | 2019-04-11 |
| JP2019509748A5 true JP2019509748A5 (enExample) | 2020-04-09 |
Family
ID=59966430
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018550831A Withdrawn JP2019509748A (ja) | 2016-03-30 | 2017-03-30 | 組換えタンパク質及び／又はウイルスベクター製造のための細胞株 |
| JP2022070121A Pending JP2022101642A (ja) | 2016-03-30 | 2022-04-21 | 組換えタンパク質及び／又はウイルスベクター製造のための細胞株 |
| JP2025019374A Pending JP2025087704A (ja) | 2016-03-30 | 2025-02-07 | 組換えタンパク質及び／又はウイルスベクター製造のための細胞株 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022070121A Pending JP2022101642A (ja) | 2016-03-30 | 2022-04-21 | 組換えタンパク質及び／又はウイルスベクター製造のための細胞株 |
| JP2025019374A Pending JP2025087704A (ja) | 2016-03-30 | 2025-02-07 | 組換えタンパク質及び／又はウイルスベクター製造のための細胞株 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20190078099A1 (enExample) |
| EP (1) | EP3436576A4 (enExample) |
| JP (3) | JP2019509748A (enExample) |
| KR (1) | KR102479894B1 (enExample) |
| CN (1) | CN109563496B (enExample) |
| AU (2) | AU2017244133A1 (enExample) |
| BR (1) | BR112018070250A2 (enExample) |
| CA (1) | CA3019126A1 (enExample) |
| MX (1) | MX2018011928A (enExample) |
| SG (1) | SG11201808398PA (enExample) |
| WO (1) | WO2017173043A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3215191B1 (en) | 2014-11-05 | 2024-08-14 | Voyager Therapeutics, Inc. | Aadc polynucleotides for the treatment of parkinson's disease |
| KR20230145206A (ko) | 2014-11-14 | 2023-10-17 | 보이저 테라퓨틱스, 인크. | 조절성 폴리뉴클레오티드 |
| CN114717264A (zh) | 2014-11-14 | 2022-07-08 | 沃雅戈治疗公司 | 治疗肌萎缩性侧索硬化(als)的组合物和方法 |
| US11697825B2 (en) | 2014-12-12 | 2023-07-11 | Voyager Therapeutics, Inc. | Compositions and methods for the production of scAAV |
| US10584337B2 (en) | 2016-05-18 | 2020-03-10 | Voyager Therapeutics, Inc. | Modulatory polynucleotides |
| KR20200018488A (ko) | 2017-05-24 | 2020-02-19 | 토리스 게엠베하 | 고암모니아혈증을 치료하기 위한 글루타민 합성효소의 용도 |
| JOP20190269A1 (ar) | 2017-06-15 | 2019-11-20 | Voyager Therapeutics Inc | بولي نوكليوتيدات aadc لعلاج مرض باركنسون |
| JP2020525003A (ja) * | 2017-06-21 | 2020-08-27 | バートナム，ティモシー，エー． | 腎臓病治療のための免疫特権を有する生物活性腎細胞 |
| MX2020004035A (es) | 2017-10-20 | 2020-11-09 | Res Inst Nationwide Childrens Hospital | Métodos y materiales para terapia génica con nt-3. |
| CN112424359A (zh) | 2018-05-15 | 2021-02-26 | 沃雅戈治疗公司 | 用于治疗帕金森氏病的组合物和方法 |
| WO2020012446A1 (en) * | 2018-07-13 | 2020-01-16 | Enzene Biosciences Limited | Double knock-out cho cell line method of its generation and producing therapeutic proteins therefrom |
| US12281321B2 (en) | 2018-09-28 | 2025-04-22 | Voyager Therapeutics, Inc. | Frataxin expression constructs having engineered promoters and methods of use thereof |
| AU2019354296A1 (en) * | 2018-10-01 | 2021-04-29 | Ultragenyx Pharmaceutical Inc. | Gene therapy for treating propionic acidemia |
| US12686874B2 (en) | 2020-03-31 | 2026-07-21 | Ultragenyx Pharmaceutical Inc. | Gene therapy for treating propionic acidemia |
| US12054738B2 (en) | 2020-07-30 | 2024-08-06 | Shape Therapeutics Inc. | Stable cell lines for inducible production of rAAV virions |
| EP4269570A4 (en) * | 2020-12-25 | 2025-04-30 | Agc Inc. | Viral vector-producing cells with improved vector-producing capacity, methods for producing the same, and methods for selecting them |
| EP4301861A1 (en) | 2021-03-03 | 2024-01-10 | Shape Therapeutics Inc. | Auxotrophic cells for virus production and compositions and methods of making |
| AR127674A1 (es) | 2021-10-18 | 2024-02-21 | Regeneron Pharma | Células de mamífero que comprenden genes cas9 integrados para producir sitios de integración estables, y células de mamífero que comprenden sitios de integración estables y otros sitios |
| JP2024537896A (ja) | 2021-10-18 | 2024-10-16 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | アデノウイルス随伴ウイルスポリヌクレオチドを含む真核細胞 |
| WO2023150506A2 (en) * | 2022-02-01 | 2023-08-10 | Shape Therapeutics Inc. | STABLE CELL LINES FOR INDUCIBLE PRODUCTION OF rAAV VIRIONS |
| EP4514844A1 (en) | 2022-04-29 | 2025-03-05 | Broadwing Bio LLC | Complement factor h related 4-specific antibodies and uses thereof |
| CN119487063A (zh) | 2022-04-29 | 2025-02-18 | 博闻生物有限责任公司 | 双特异性抗体以及治疗眼部疾病的方法 |
| AU2023259251A1 (en) | 2022-04-29 | 2024-11-14 | Broadwing Bio, Inc. | Angiopoietin-related protein 7-specific antibodies and uses thereof |
| WO2024227154A1 (en) | 2023-04-28 | 2024-10-31 | Broadwing Bio Llc | Complement component 3 (c3)-specific antibodies and uses thereof |
| CN122349567A (zh) | 2023-12-11 | 2026-07-07 | 济世易为生物有限公司 | 利用反式剪接和拆分型选择标记的蛋白质表达 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080001001A1 (en) * | 2006-04-17 | 2008-01-03 | Pevnick Stephen H | Pneumatic Activated Fountain |
| WO2007136685A2 (en) * | 2006-05-19 | 2007-11-29 | Sangamo Biosciences, Inc. | Methods and compositions for inactivation of dihydrofolate reductase |
| JP5756016B2 (ja) * | 2008-10-29 | 2015-07-29 | サンガモ バイオサイエンシーズ， インコーポレイテッド | グルタミンシンセターゼ遺伝子の発現を不活性化する方法及び組成物 |
| AU2015201300A1 (en) * | 2008-10-29 | 2015-04-02 | Sangamo Therapeutics, Inc. | Methods and Compositions For Inactivating Glutamine Synthetase Gene Expression |
| EP3683319A1 (en) * | 2011-06-01 | 2020-07-22 | Precision Biosciences, Inc. | Methods and products for producing engineered mammalian cell lines with amplified transgenes |
| BR112014020325A2 (pt) * | 2012-02-17 | 2017-08-08 | Childrens Hospital Philadelphia | composições de vetor do aav e métodos para a transferência de gene para as células, órgãos e tecidos |
| PT2970920T (pt) * | 2013-03-15 | 2018-07-30 | Childrens Hospital Philadelphia | Processo de fabrico escalável para produzir vetores lentivirais recombinantes em sistema de cultura de células de suspensão livres de soro |
| NZ716102A (en) * | 2013-07-22 | 2021-12-24 | The Children’S Hospital Of Philadelphia | Variant aav and compositions, methods and uses for gene transfer to cells, organs and tissues |
| KR20170081784A (ko) * | 2016-01-04 | 2017-07-13 | 한국과학기술원 | Gs 유전자가 결핍된 신규한 hek293 세포주 및 상기 형질전환된 hek293 숙주세포를 이용한 목적 단백질의 생산 방법 |
-
2017
- 2017-03-30 WO PCT/US2017/024951 patent/WO2017173043A1/en not_active Ceased
- 2017-03-30 BR BR112018070250A patent/BR112018070250A2/pt not_active Application Discontinuation
- 2017-03-30 MX MX2018011928A patent/MX2018011928A/es unknown
- 2017-03-30 KR KR1020187031368A patent/KR102479894B1/ko active Active
- 2017-03-30 SG SG11201808398PA patent/SG11201808398PA/en unknown
- 2017-03-30 EP EP17776630.0A patent/EP3436576A4/en active Pending
- 2017-03-30 JP JP2018550831A patent/JP2019509748A/ja not_active Withdrawn
- 2017-03-30 AU AU2017244133A patent/AU2017244133A1/en not_active Abandoned
- 2017-03-30 US US16/088,693 patent/US20190078099A1/en active Pending
- 2017-03-30 CA CA3019126A patent/CA3019126A1/en active Pending
- 2017-03-30 CN CN201780022183.9A patent/CN109563496B/zh active Active
-
2022
- 2022-04-21 JP JP2022070121A patent/JP2022101642A/ja active Pending
-
2023
- 2023-06-26 AU AU2023204029A patent/AU2023204029B2/en active Active
-
2025
- 2025-02-07 JP JP2025019374A patent/JP2025087704A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016185153A5 (enExample) | ||
| AU2023204029B2 (en) | Cell line for recombinant protein and/or viral vector production | |
| FI3517134T3 (fi) | Adeno-assosioituneen viruksen (aav) serotyypin 8 sekvenssejä, niitä sisältäviä vektoreita ja niiden käyttöjä | |
| JP2018121653A5 (enExample) | ||
| FI3488007T3 (fi) | Skaalautuvia korkeasaantoisia menetelmiä adeno-assosioidun rekombinanttiviruksen (rAAV) vektorin tuottamiseksi korkealla saannolla ja siten tuotettuja adeno-assosioidun rekombinanttiviruksen (rAAV) vektoreita | |
| JP2024073614A (ja) | プラスミドを用いないａａｖベクター産生細胞株 | |
| Backliwal et al. | High‐density transfection with HEK‐293 cells allows doubling of transient titers and removes need for a priori DNA complex formation with PEI | |
| CN105283553B (zh) | 蛋白质富集的微泡及其制备和使用方法 | |
| US7056502B2 (en) | Recombinant aav vectors with AAV5 capsids and AAV5 vectors pseudotyped in heterologous capsids | |
| TWI478937B (zh) | 改良之哺乳動物表現載體及其用途 | |
| JP2022097744A (ja) | 緩衝剤溶液を提供するための方法及びシステム | |
| CN104781389B (zh) | 蛋白质生产促进剂 | |
| CN113631711A (zh) | 核酸的靶向整合 | |
| US20190093126A1 (en) | Large commercial scale lentiviral vector production system and vectors produced thereby | |
| NZ747127B2 (en) | Cell line for recombinant protein and/or viral vector production | |
| EP4578952A1 (en) | Method for introducing nucleic acid into cells and application thereof | |
| WO2022261475A1 (en) | Methods of regulating adeno-associated virus production | |
| Mistry | Thermoresponsive Elastin-like Polypeptide Triblock for Cell Encapsulation and 3D Bioprinting Applications | |
| CN121443633A (zh) | 掺入驱动可选择标记表达的启动子组合的载体 | |
| US20250188447A1 (en) | Modular vector (modvec) system: a platform for construction of next generation expression vectors | |
| CN120435566A (zh) | 用于产生腺相关病毒的微链dna | |
| CN117897401A (zh) | 平台宿主对igf-培养基的适应 | |
| DePalma | Optimizing Cell Lines Improves Production—Really! | |
| HK40041212A (en) | Targeted integration of nucleic acids | |
| RU2016152555A (ru) | РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pBiPr-ABIgA2m1F16-ht ДЛЯ ПОЛУЧЕНИЯ РЕКОМБИНАНТНОГО ИММУНОГЛОБУЛИНА А ИЗОТИПА IGA2m1 |